• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • DMF (Drug Master Filing) – Pharmaceutical Products
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • CML (China Manufacture Licence) – Pressure vessels
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Company Profile
    • Partners
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Information
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • DMF
      • CCC
      • Pressure Vessels
    • Publications
    • Brochure
    • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • NMPA Initiates Working Plan for Medical Device Sampling Inspection

NMPA Initiates Working Plan for Medical Device Sampling Inspection

Sampling Inspection
Wednesday, 03 June 2020 / Published in Medical Device

NMPA Initiates Working Plan for Medical Device Sampling Inspection

On 13.05.2020, the NMPA (National Medical Products Administration) published a notice (No.46-2020) with further details on the recently implemented medical device sampling inspection requirements. It addresses the important work items for inspection, reinspection, objections and appeals, and other requirements based on the administrative measures (No.09-2020) released on 13th March. A high level summary of the measures is set out below.

Inspection
All provincial MPAs (Medical Product Administration) and the National Institutes for Food and Drug Control should refer to detailed requirements set out behind Annex 1 and Annex 2 of the Notice for conducting sampling inspections on medical devices in China. Both of the Annexes outline the specific regulatory standards, inspection items, and principles for determining the inspection results.

Reinspection
According to Rule 32 in the NMPA’s administrative measures (No.09-2020) for sampling inspection on medical devices, an application for an appeal reinspection can be made by the NMPA Legal Agent who is dissatisfied with the results of the inspection report. Such application must be made within 7 working days following the day on which the inspection report was received.

Objections & appeals
The application for an appeal reinspection must be submitted to the corresponding provincial MPA, in written form and should include any materials as proof, within 7 working days following the day on which the inspection report was received.

The respective provincial MPA should file a report within 2 working days following the day on which the application was received. The National Institutes for Food and Drug Control should receive a revalidation of the inspection results and suggestions from the local MPA within 15 working days.

Other requirements
According to Rule 30 in the NMPA’s administrative measures (No.09-2020) for sampling inspection on medical devices, if the NMPA Legal Agent claims that the sample product is not the same original product, the NMPA Legal Agent must submit any related materials to the respective local MPA as proof.

Also, the NMPA Legal Agent must submit the materials within 7 working days following the day on which the inspection report was received.

Read more from our prior news about the NMPA‘s administrative measures (No.09-2020) for sampling inspection on medical devices.

By Jacky Li. Contact Cisema to learn more.

Tagged under: Medical Devices, Sampling Inspection

What you can read next

Medical Device Electronic Submission System
Reminder for Start of Medical Devices’ UDI Code Labeling Requirement
AI Regulatory Developments and Planning Issued by China Regulator

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Drug Master Filing
      • Health Food
      • Medical Device
    • RoHS
  • Publications
  • Seminars
  • Webinars

Recent Posts

  • Updates on the Medical Device Classification Catalogue in China

    On December 31, 2020, the NMPA announced (No.14...
  • Cisema Partners with Advamed

    Cisema is delighted to announce it is now an as...
  • Guidelines for Sampling Testing on Organic Foods

    On December 4, 2020, the CNCA (Certification an...
  • Draft of Prohibited List and Existing List of Cosmetic Ingredients Announced

    On January 22, 2021, the NIFDC (China National ...
  • Guideline and Standard Update for Medical Devices & IVDs in January and February 2021

    China Regulatory Guidelines Issued / Updated Th...

Archive

Cisema

With nine locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Events
  • News & Information
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2019 Cisema. All rights reserved.

TOP